frequent in-frame somatic deletions activate gp130 inflammatory hepatocellular tumours 
inflammatory hepatocellular adenomas benign liver tumours defined presence inflammatory infiltrates increased expression inflammatory proteins tumour hepatocytes show marked activation interleukin il signalling pathway tumour type sequencing candidate genes pinpointed response somatic gain function mutations il6st gene encodes signalling co receptor gp130 indeed % inflammatory hepatocellular adenomas harbour small frame deletions target binding site gp130 il expression four different gp130 mutants hepatocellular cells activates signal transducer activator transcription stat3 absence ligand furthermore analysis hepatocellular carcinomas revealed rare gp130 alterations always accompanied beta-catenin-activating mutations suggesting cooperative effect signalling pathways malignant conversion hepatocytes recurrent gain function gp130 mutations human hepatocellular adenomas fully explains activation acute inflammatory phase observed tumourous hepatocytes suggests similar alterations may occur inflammatory epithelial tumours stat3 activation 
